195 related articles for article (PubMed ID: 25790192)
1. Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome.
Karlsen M; Hansen T; Nordal HH; Brun JG; Jonsson R; Appel S
PLoS One; 2015; 10(3):e0120383. PubMed ID: 25790192
[TBL] [Abstract][Full Text] [Related]
2. TLR-7 and -9 Stimulation of Peripheral Blood B Cells Indicate Altered TLR Signalling in Primary Sjögren's Syndrome Patients by Increased Secretion of Cytokines.
Karlsen M; Jonsson R; Brun JG; Appel S; Hansen T
Scand J Immunol; 2015 Dec; 82(6):523-31. PubMed ID: 26332048
[TBL] [Abstract][Full Text] [Related]
3. H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.
Brauner S; Folkersen L; Kvarnström M; Meisgen S; Petersen S; Franzén-Malmros M; Mofors J; Brokstad KA; Klareskog L; Jonsson R; Westerberg LS; Trollmo C; Malmström V; Ambrosi A; Kuchroo VK; Nordmark G; Wahren-Herlenius M
Ann Rheum Dis; 2017 Oct; 76(10):1755-1763. PubMed ID: 28760805
[TBL] [Abstract][Full Text] [Related]
4. Expression of Toll-like receptors 7, 8, and 9 in primary Sjögren's syndrome.
Zheng L; Zhang Z; Yu C; Yang C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):844-50. PubMed ID: 20399690
[TBL] [Abstract][Full Text] [Related]
5. Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome.
Davies R; Sarkar I; Hammenfors D; Bergum B; Vogelsang P; Solberg SM; Gavasso S; Brun JG; Jonsson R; Appel S
Front Immunol; 2019; 10():281. PubMed ID: 30846988
[TBL] [Abstract][Full Text] [Related]
6. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.
Shimizu T; Nakamura H; Takatani A; Umeda M; Horai Y; Kurushima S; Michitsuji T; Nakashima Y; Kawakami A
Clin Exp Immunol; 2019 Apr; 196(1):39-51. PubMed ID: 30446998
[TBL] [Abstract][Full Text] [Related]
7. Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.
Vogelsang P; Karlsen M; Brun JG; Jonsson R; Appel S
Arthritis Res Ther; 2014 Aug; 16(4):R166. PubMed ID: 25113744
[TBL] [Abstract][Full Text] [Related]
8. Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjögren's syndrome.
Ainola M; Porola P; Takakubo Y; Przybyla B; Kouri VP; Tolvanen TA; Hänninen A; Nordström DC
Clin Exp Immunol; 2018 Mar; 191(3):301-310. PubMed ID: 29105068
[TBL] [Abstract][Full Text] [Related]
9. Activation of Toll-Like Receptor 7 Signaling Pathway in Primary Sjögren's Syndrome-Associated Thrombocytopenia.
Zhang S; Qu J; Wang L; Li M; Xu D; Zhao Y; Zhang F; Zeng X
Front Immunol; 2021; 12():637659. PubMed ID: 33767707
[No Abstract] [Full Text] [Related]
10. Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation.
Saadoun D; Terrier B; Bannock J; Vazquez T; Massad C; Kang I; Joly F; Rosenzwajg M; Sene D; Benech P; Musset L; Klatzmann D; Meffre E; Cacoub P
Arthritis Rheum; 2013 Apr; 65(4):1085-96. PubMed ID: 23279883
[TBL] [Abstract][Full Text] [Related]
11. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
[TBL] [Abstract][Full Text] [Related]
12. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome.
Bohnhorst JØ; Bjørgan MB; Thoen JE; Natvig JB; Thompson KM
J Immunol; 2001 Oct; 167(7):3610-8. PubMed ID: 11564773
[TBL] [Abstract][Full Text] [Related]
13. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.
Aqrawi LA; Ivanchenko M; Björk A; Ramírez Sepúlveda JI; Imgenberg-Kreuz J; Kvarnström M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M
Clin Exp Immunol; 2018 Jun; 192(3):259-270. PubMed ID: 29453859
[TBL] [Abstract][Full Text] [Related]
14. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
Front Immunol; 2021; 12():701656. PubMed ID: 34413853
[TBL] [Abstract][Full Text] [Related]
15. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
[TBL] [Abstract][Full Text] [Related]
16. Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome.
Miceli-Richard C; Wang-Renault SF; Boudaoud S; Busato F; Lallemand C; Bethune K; Belkhir R; Nocturne G; Mariette X; Tost J
Ann Rheum Dis; 2016 May; 75(5):933-40. PubMed ID: 26183421
[TBL] [Abstract][Full Text] [Related]
17. Expression of Toll-Like Receptors in Peripheral Blood Mononuclear Cells of Patients with Primary Sjögren's Syndrome.
Karlsen M; Jakobsen K; Jonsson R; Hammenfors D; Hansen T; Appel S
Scand J Immunol; 2017 Mar; 85(3):220-226. PubMed ID: 27943374
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immunoglobulin heavy chain rearrangements between peripheral and glandular B cells in a patient with primary Sjögren's syndrome.
Hansen A; Jacobi A; Pruss A; Kaufmann O; Scholze J; Lipsky PE; Dörner T
Scand J Immunol; 2003 May; 57(5):470-9. PubMed ID: 12753504
[TBL] [Abstract][Full Text] [Related]
19. Elevated EPSTI1 promote B cell hyperactivation through NF-κB signalling in patients with primary Sjögren's syndrome.
Sun JL; Zhang HZ; Liu SY; Lian CF; Chen ZL; Shao TH; Zhang S; Zhao LL; He CM; Wang M; Zhang W; Chen H; Zhang FC
Ann Rheum Dis; 2020 Apr; 79(4):518-524. PubMed ID: 32114510
[TBL] [Abstract][Full Text] [Related]
20. Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome.
Pontarini E; Fabris M; Quartuccio L; Cappeletti M; Calcaterra F; Roberto A; Curcio F; Mavilio D; Della Bella S; De Vita S
Rheumatology (Oxford); 2015 Aug; 54(8):1429-34. PubMed ID: 25740829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
